Midwest Institute For Addiction is an addiction treatment center situated at 711 Old Ballas Road, Suite 203 in the 63141 zip code of Saint Louis, MO.
It is run by a private for-profit organization. Midwest Institute For Addiction offers prescribes suboxone, relapse prevention from naltrexone and buprenorphine detox. Midwest Institute For Addiction provides outpatient methadone/buprenorphine or naltrexone treatment, IOT and regular outpatient treatment. Some of the treatment approaches used by Midwest Institute For Addiction include motivational interviewing, rational emotive behavioral therapy and brief intervention. Midwest Institute For Addiction also provides detox services that include inpatient alcohol detoxification, residential benzodiazepines detoxification and inpatient opioid detox. It provides residential substance use treatment and inpatient detoxification. Other addiction treatment offered includes internet use disorder treatment and treatment for non-substance use addiction disorder.
Here are the full facility listing details on Midwest Institute for Addiction in Saint Louis, MO:
Types of Care:
- inpatient detoxification
- residential substance abuse treatment
Service Settings:
- outpatient services
- outpatient detox
- outpatient day treatment
- intensive outpatient treatment program
- outpatient methadone/buprenorphine or naltrexone treatment
- regular outpatient treatment
Opioid Medications used in Treatment:
- Buprenorphine treatment
- Naltrexone clinical treatment
Type of Alcohol Use Disorder Treatment:
- Prescribes medication for alcohol use disorder
Type Of Treatment:
- buprenorphine detox
- suboxone prescription
- administers naltrexone
- relapse prevention from naltrexone
Pharmacotherapies:
- Acamprosate (Campral)
- Disulfiram (Antabuse)
- Buprenorphine sub-dermal implant (Probuphine)
- Buprenorphine with naloxone (Ex. Suboxone)
- Buprenorphine without naloxone
- Buprenorphine (extended-release, injectable, for example, Sublocade)
- Naltrexone (oral)
- Naltrexone (extended-release, injectable naltrexone - Vivitrol)
- Medications for psychiatric disorders
- Clonidine
Treatment Approaches:
- brief intervention services
- cognitive behavioral therapy
- motivational incentives
- motivational interviewing
- matrix model
- rational emotive behavioral therapy
- relapse prevention
- counseling for substance abuse
- counseling for trauma victims
- 12-step rehab
Facility Ownership:
- a private for-profit organization
License/Certification/Accreditation:
- State substance abuse agency
- State department of health
- State mental health department
- Certified by Commission on Accreditation of Rehabilitation Facilities
Payment/Insurance/Funding Accepted:
- Accepts Military insurance
- Accepts private health insurance
- Accepts cash or self-payment
Assessment/Pre-treatment:
- Comprehensive substance use assessment
Screening & Testing:
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Screening for mental disorders
- Screening for substance use
Transitional Services:
- Aftercare/continuing care
- Discharge Planning
- Outcome follow-up after discharge
Ancillary Services:
- Case management
- Housing services
- Mental health services
- Social skills development
Other Addictions Treatment:
- treatment for non-substance use addiction disorder
- internet use disorder treatment
Detoxification:
- inpatient alcohol detox
- residential benzodiazepines detox
- cocaine detox
- methamphetamines detoxification
- inpatient opioid detox
Counseling Services and Education:
- individual counseling
- counseling for groups
- counseling for families
- counseling for couples
- substance use education
Tobacco/Screening Services:
- Nicotine replacement therapy
- Non-nicotine smoking/tobacco cessation medications
- Screening for tobacco use
- Smoking/tobacco cessation counseling
Facility Smoking Policy:
- Smoking permitted in designated area
Age Groups Accepted:
- accepts adults
- accepts young adults over 18
Gender Accepted:
